HSIA welcomes debate on perc assessment

11 July 2008


The draft appears on the EPA’s Integrated Risk Information System (IRIS), an on-line database of summary health risk assessments and regulatory information on specific chemicals, developed to provide consistent risk information for EPA decisions.

Representing the manufacturers of perc, HSIA has sponsored a number of studies on the solvent. This included an epidemiology study of drycleaning workers in the Nordic countries, which found no evidence of an increased cancer risk related to perc exposure.

Perc is currently used by an estimated 70% of drycleaners in the USA. The EPA’s draft assessment was released for public comment in late June 2008 and will be reviewed by a special panel of the National Academy of Sciences this autumn. It is the first such IRIS assessment to incorporate a comprehensive analysis of associated uncertainties.

The International Agency for Research on Cancer (IARC) convened a panel of internationally regarded experts which concluded in 1995 that perc is "probably carcinogenic to humans," based on limited evidence of carcinogenicity in humans and sufficient evidence in animals.

Although a number of studies of workers exposed to perc have been conducted, the HSIA-sponsored epidemiology study of drycleaning workers in the Nordic countries was the first to compare cancer incidence among exposed workers with those in a similar socioeconomic group (i.e., laundry workers). The study also included all drycleaning workers in the four Nordic countries and represents the largest group of drycleaning workers ever studied. In addition, HSIA has sponsored several toxicology studies as part of voluntary agreements with EPA and the Agency for Toxic Substances and Disease Registry, including studies of the potential developmental, neurotoxic, and immunotoxic effects of perc.




Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.